top of page
MirZyme Therapeutics offers the end-to-end preeclampsia solution. It is an early-stage clinical women's health biopharmaceutical company that has uncovered what causes preeclampsia and how to predict and prevent it. We have a pipeline of tailored therapeutics to prevent preeclampsia and Small for Gestational Age babies.
Our digital diagnostic algorithm takes blood test results and tells a pregnant woman half way through pregnancy if she is going to develop preeclampsia.
MirZyme has a highly skilled, diverse, and deeply dedicated team. The core team have worked together for over a decade.
Who are we
$40M non-dilutive competitive grants awarded leading to breakthrough innovation
Global patents granted in 30 countries
Novel diagnostic algorithm proven in human clinical trials
Fast-track Innovation Passport awarded by Medicines & Healthcare products Regulatory Agency for development of MirZyme's primary medicine
Recognized by Department for Science, Innovation & Technology as a UK leading FemTech in Biotechology
Get in touch
To get in touch with the team please fill out the form below
MirZyme Therapeutics, Birmingham, B7 4BB, UK
bottom of page